• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Stem Cell Subgroup Shows Retinal Regeneration Efficacy in Degeneration Models

by
November 12, 2026
in Health
Reading Time: 2 mins read
0
Stem Cell Subgroup Shows Retinal Regeneration Efficacy in Degeneration Models

Stem Cell Subgroup Shows Retinal Regeneration Efficacy in Degeneration Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A functionally enhanced subgroup of human retinal progenitor cells demonstrates notable integration and promotes structural and functional recovery when transplanted into retinal degenerative disease models, according to research published in the Journal of Translational Medicine. Retinal degenerative conditions currently lack therapies capable of reversing photoreceptor loss, which remains a substantial hurdle for visual regenerative medicine. While retinal cells derived from human induced pluripotent stem cells have shown therapeutic potential, their translation into clinical settings has been hindered by low differentiation efficiency and poor post-transplantation cell survival.

To overcome these limitations, the research team established a stable and expandable differentiation platform designed to generate retinal progenitor cells from human induced pluripotent stem cells within three weeks. This differentiation protocol relies on a chemically defined medium with a clearly defined composition, offering a standardized and repeatable preparation route.

Through single-cell cloning, the investigators isolated a specific cellular subpopulation designated as human retinal progenitor cell 1, or hRPC1. Profiling revealed that hRPC1 cells exhibited increased mitochondrial activity alongside distinct metabolic features. Specifically, the subgroup demonstrated enhanced dopamine metabolism associated with sulfotransferase 1A4, an enzyme identified as a key candidate regulator supporting cellular energetics and redox homeostasis.

The study showed that SULT1A4-associated dopamine metabolism plays a central role in stabilizing mitochondrial function and conferring cellular resistance against oxidative stress.

In experimental models of retinal degeneration, transplanted hRPC1 cells displayed marked migration and integrated directly into the host retina. Following this integration, recipient models demonstrated substantial structural preservation across the retinal layers along with measurable visual functional recovery over an observation window of four to eight weeks. These findings confirm that the isolated subpopulation possesses the biological capacity to support retinal repair in vivo.

The identification of SULT1A4 as an associated regulator highlights a defined molecular target for screening and optimizing cell-based treatments for retinal degenerative disorders. By establishing a chemically defined, three-week differentiation platform and isolating a functionally superior progenitor subgroup, the findings provide a novel strategy for identifying highly active, transplantable human retinal progenitor cells to improve the therapeutic efficacy of future stem cell transplantation therapies.

Subject of Research: Stem cell-derived retinal progenitor cells and SULT1A4 in retinal regeneration

Article Title: SULT1A4 is associated with a subpopulation of human iPSC–derived retinal progenitor cells with pronounced migration and regenerative efficacy in RD models

Article References: Liu, Y., Li, C., Cui, T., Huang, H., Chen, J., Zhou, Y., Li, J., Tian, H., Gao, F., Zhang, J., Wang, J., Xu, J.-Y., Zhu, L., Zhang, J., Xu, G.-T., Ou, Q., Lu, L., Bi, Y., & Jin, C. (2026). SULT1A4 is associated with a subpopulation of human iPSC–derived retinal progenitor cells with pronounced migration and regenerative efficacy in RD models. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09175-x

Image Credits: AI Generated

DOI: 10.1186/s12967-026-09175-x

Keywords: retinal degeneration, retinal progenitor cells, induced pluripotent stem cells, SULT1A4, mitochondrial homeostasis, dopamine metabolism, stem cell transplantation, cell-based therapy, visual regenerative medicine, photoreceptor loss, chemically defined medium, oxidative stress resistance, host retina integration, functional recovery, cellular energetics, single cell cloning

News Source: Drew Townsend. (November 12, 2026). Stem Cell Subgroup Shows Retinal Regeneration Efficacy in Degeneration Models. Scienmag.

Tags: cell-based therapycellular energeticschemically defined mediumdopamine metabolismfunctional recoveryhost retina integrationinduced pluripotent stem cellsMitochondrial Homeostasisoxidative stress resistancephotoreceptor lossretinal degenerationretinal progenitor cellssingle-cell cloningstem cell transplantationSULT1A4visual regenerative medicine
Share12Tweet7Share2ShareShareShare1

Related Posts

No Clear Evidence Links Bulimia Nervosa to Reduced Cardiac Interoceptive Accuracy

No Clear Evidence Links Bulimia Nervosa to Reduced Cardiac Interoceptive Accuracy

November 18, 2026
Obesity Links to Poorer Physical Health Among Breast Cancer Survivors

Obesity Links to Poorer Physical Health Among Breast Cancer Survivors

November 18, 2026

Wheat Pathogen Multidrug Resistance Driven by Transposons and Polygenic Architecture

November 18, 2026

Dual-Targeted CAR-T Therapy Clears Cancer Signs in Phase 1 Myeloma Trial

November 18, 2026

POPULAR NEWS

  • Over Forty Percent of Northeast Ethiopian Neonates Experience Early Cord Clamping

    Over Forty Percent of Northeast Ethiopian Neonates Experience Early Cord Clamping

    29 shares
    Share 12 Tweet 7
  • Biomimetic Hydroxyapatite Coating Restores Elastic Modulus in Recycled Aggregate Concrete

    29 shares
    Share 12 Tweet 7
  • Early Shoulder Mobilization Accelerates Initial Motion but Yields Equivalent Annual Outcomes

    29 shares
    Share 12 Tweet 7
  • SGLT2 Inhibitor Use Associated With Lower Proteinuria Rates During Bevacizumab Therapy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

No Clear Evidence Links Bulimia Nervosa to Reduced Cardiac Interoceptive Accuracy

Obesity Links to Poorer Physical Health Among Breast Cancer Survivors

Beam-Membrane Vocal Fold Model Captures Laryngeal Posturing and Phonation Dynamics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.